Information

A Breakthrough Through Dual Mechanisms: How Tes...

In the treatment of diabetes and obesity, the advent of tesipatide (trade name Mounjaro/Zepbound) marks the arrival of the era of dual agonists. Developed by Eli Lilly, this GIP/GLP-1 receptor...

Trelagliptin Succinate Tablets: A Balanced Choi...

Did you take your medicine today? 🗣️ Has this phrase become the persistent background noise after your daily meals? For many people with type 2 diabetes, controlling blood sugar feels...

Real user feedback from Lebo Leisheng: Some peo...

When was the last time you fell asleep the moment your head hit the pillow and slept soundly until morning, waking up refreshed? 🌙 For many, this is a memory...

Real-life case of oral semaglutide: How did she...

From gaining weight even from drinking water to having "freedom to dress as she pleases," her journey to success is truly remarkable. ✨ “I’ve really tried everything: dieting, jumping rope,...

The mystery of an 8-hour half-life: Why Dali Re...

Friend, have you ever experienced a night like this: counting thousands of sheep, listening to all sorts of sleep-inducing white noise, yet still staring at the ceiling awake at three...

Say goodbye to a "fat liver"! GLP-1 drugs may b...

Today, we'll talk about a "silent killer" —non-alcoholic fatty liver disease (NAFLD) . It's painless and asymptomatic, yet it quietly affects nearly a third of the world's population! Many people...